JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.95% |
| 2 | Financials | 11.95% |
| 3 | Healthcare | 9.46% |
| 4 | Consumer Discretionary | 8.62% |
| 5 | Industrials | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4751
Bank7 Corp
BSVN
$496M
| $90K | ﹤0.01% |
4,774
+3,035
| +175% | +$56.6K |
|
4752
Great Elm Capital Corp
GECC
$80M
| $90K | ﹤0.01% |
1,933
-67
| -3% | -$3.26K |
|
4753
SEACOR Marine Holdings
SMHI
$262M
| $90K | ﹤0.01% |
6,496
+38
| +0.6% | +$495 |
|
|
STR
4754
DELISTED
Sitio Royalties
STR
| $89K | ﹤0.01% |
3,176
+13
| +0.4% | +$331 |
|
|
ASNA
4755
DELISTED
Ascena Retail Group, Inc.
ASNA
| $89K | ﹤0.01% |
11,580
+9,013
| +351% | +$73.9K |
|
4756
Coca-Cola Femsa
KOF
$23B
| $88K | ﹤0.01% |
1,447
+424
| +41% | +$24.9K |
|
4757
Purple Innovation
PRPL
$30.2M
| $88K | ﹤0.01% |
405
+356
| +727% | +$68.6K |
|
4758
Celcuity
CELC
$4.38B
| $87K | ﹤0.01% |
8,127
+6,134
| +308% | +$80.3K |
|
4759
Diana Shipping
DSX
$292M
| $87K | ﹤0.01% |
40,352
+25,763
| +177% | +$62.4K |
|
4760
Lexicon Pharmaceuticals
LXRX
$1.06B
| $87K | ﹤0.01% |
21,153
+1,782
| +9% | +$6.86K |
|
4761
Siebert Financial
SIEB
$71.6M
| $87K | ﹤0.01% |
9,995
+7,508
| +302% | +$71.8K |
|
4762
SIGA Technologies
SIGA
$205M
| $87K | ﹤0.01% |
18,167
+107
| +0.6% | +$545 |
|
4763
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.23B
| $87K | ﹤0.01% |
1,067
-1,600
| -60% | -$129K |
|
4764
Xtrackers USD High Yield Corporate Bond ETF
HYLB
$3.48B
| $86K | ﹤0.01% |
2,128
+529
| +33% | +$21.1K |
|
|
IMOS
4765
ChipMOS TECHNOLOGIES
IMOS
$1.98B
| $86K | ﹤0.01% |
+3,825
| New | +$84.3K |
|
4766
Stoke Therapeutics
STOK
$2.15B
| $86K | ﹤0.01% |
3,019
+18
| +0.6% | +$453 |
|
|
HOME
4767
DELISTED
At Home Group Inc.
HOME
| $86K | ﹤0.01% |
15,628
-602,968
| -97% | -$4.91M |
|
|
CBL
4768
DELISTED
CBL& Associates Properties, Inc.
CBL
| $86K | ﹤0.01% |
81,992
-1,120,065
| -93% | -$1.47M |
|
|
GNC
4769
DELISTED
GNC Holdings, Inc.
GNC
| $86K | ﹤0.01% |
32,092
+1,242
| +4% | +$3.32K |
|
|
ELGX
4770
DELISTED
Endologix Inc
ELGX
| $86K | ﹤0.01% |
54,212
-65,851
| -55% | -$184K |
|
4771
American Coastal Insurance
ACIC
$465M
| $85K | ﹤0.01% |
6,760
| – | – |
|
|
CSCI
4772
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
| $84K | ﹤0.01% |
922
| – | – |
|
4773
Titan International
TWI
$451M
| $83K | ﹤0.01% |
22,916
-221,195
| -91% | -$659K |
|
4774
VolitionRx Ltd
VNRX
$7.8M
| $83K | ﹤0.01% |
876
-1,194
| -58% | -$124K |
|
4775
Forestar Group
FOR
$1.47B
| $82K | ﹤0.01% |
3,949
-15,842
| -80% | -$310K |
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.